Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP972214.RA41EAnEhqEjvwQupD8e0zF4l6DtwyjlxffSZda1qX7kM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP972214.RA41EAnEhqEjvwQupD8e0zF4l6DtwyjlxffSZda1qX7kM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP972214.RA41EAnEhqEjvwQupD8e0zF4l6DtwyjlxffSZda1qX7kM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP972214.RA41EAnEhqEjvwQupD8e0zF4l6DtwyjlxffSZda1qX7kM130_provenance.
- NP972214.RA41EAnEhqEjvwQupD8e0zF4l6DtwyjlxffSZda1qX7kM130_assertion description "[However, a significant fraction of patients with HER2+ breast cancer treated with these agents eventually relapse or develop progressive disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP972214.RA41EAnEhqEjvwQupD8e0zF4l6DtwyjlxffSZda1qX7kM130_provenance.
- NP972214.RA41EAnEhqEjvwQupD8e0zF4l6DtwyjlxffSZda1qX7kM130_assertion evidence source_evidence_literature NP972214.RA41EAnEhqEjvwQupD8e0zF4l6DtwyjlxffSZda1qX7kM130_provenance.
- NP972214.RA41EAnEhqEjvwQupD8e0zF4l6DtwyjlxffSZda1qX7kM130_assertion SIO_000772 22471661 NP972214.RA41EAnEhqEjvwQupD8e0zF4l6DtwyjlxffSZda1qX7kM130_provenance.
- NP972214.RA41EAnEhqEjvwQupD8e0zF4l6DtwyjlxffSZda1qX7kM130_assertion wasDerivedFrom befree-2016 NP972214.RA41EAnEhqEjvwQupD8e0zF4l6DtwyjlxffSZda1qX7kM130_provenance.
- NP972214.RA41EAnEhqEjvwQupD8e0zF4l6DtwyjlxffSZda1qX7kM130_assertion wasGeneratedBy ECO_0000203 NP972214.RA41EAnEhqEjvwQupD8e0zF4l6DtwyjlxffSZda1qX7kM130_provenance.
- befree-2016 importedOn "2016-02-19" NP972214.RA41EAnEhqEjvwQupD8e0zF4l6DtwyjlxffSZda1qX7kM130_provenance.